Xiamen Amoytop Biotech Co., Ltd.
SSE:688278.SS
73.64 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 371.822 | 412.957 | 301.241 | 285.415 | 197.164 | 205.886 | 145.064 | 83.823 | 134.663 |
| Short Term Investments
| 289.964 | 257.081 | 270.781 | 196.384 | 268.216 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 661.786 | 670.038 | 572.022 | 481.799 | 465.381 | 205.886 | 145.064 | 83.823 | 134.663 |
| Net Receivables
| 830.501 | 459.746 | 223.048 | 206.277 | 184.999 | 156.875 | 152.366 | 169.537 | 0 |
| Inventory
| 263.546 | 187.018 | 129.728 | 116.491 | 99.62 | 70.596 | 55.28 | 41.42 | 31.04 |
| Other Current Assets
| 71.257 | 23.389 | 30.813 | 29.855 | 22.584 | 27.618 | 21.14 | 170.133 | 125.33 |
| Total Current Assets
| 1,827.09 | 1,340.191 | 955.611 | 834.421 | 772.801 | 445.2 | 373.85 | 295.375 | 301.805 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 686.755 | 490.853 | 389.768 | 192.919 | 126.742 | 96.22 | 74.092 | 74.602 | 85.805 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 379.74 | 352.651 | 342.083 | 309.704 | 249.466 | 218.769 | 231.151 | 253.317 | 243.194 |
| Goodwill and Intangible Assets
| 379.74 | 352.651 | 342.083 | 309.704 | 249.466 | 218.769 | 231.151 | 253.317 | 243.194 |
| Long Term Investments
| -233.201 | -219.73 | 0 | 6.341 | 1.057 | 1.14 | 0.295 | 0.45 | 1.33 |
| Tax Assets
| 69.09 | 43.662 | 45.868 | 34.96 | 24.972 | 23.407 | 24.241 | 7.933 | 6.736 |
| Other Non-Current Assets
| 320.941 | 348.461 | 35.229 | 45.829 | 17.696 | 5.09 | 4.137 | 5.444 | 3.711 |
| Total Non-Current Assets
| 1,223.325 | 1,015.896 | 812.949 | 589.753 | 419.933 | 344.625 | 333.917 | 341.746 | 340.776 |
| Total Assets
| 3,050.415 | 2,356.087 | 1,768.56 | 1,424.175 | 1,192.734 | 789.825 | 707.766 | 637.122 | 642.581 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 60.141 | 40.625 | 97.348 | 39.278 | 18.896 | 20.253 | 10.089 | 3.207 | 3.885 |
| Short Term Debt
| 0 | -2.728 | 4.177 | 10 | 18.918 | 60.092 | 70.107 | 80 | 85 |
| Tax Payables
| 69.765 | 65.09 | 50.571 | 30.507 | 13.256 | 24.517 | 12.578 | 6.158 | 8.569 |
| Deferred Revenue
| 0 | 60.053 | 7.233 | 122.004 | 77.025 | 63.78 | 12.578 | 34.852 | 39.287 |
| Other Current Liabilities
| 290.724 | 233.726 | 115.794 | 92.258 | 63.056 | 45.863 | 37.263 | 29.204 | 34.695 |
| Total Current Liabilities
| 420.629 | 403.658 | 267.891 | 177.227 | 114.939 | 150.725 | 130.038 | 118.569 | 132.149 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 3.268 | 3.761 | 5.565 | 9.374 | 18.173 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 32.961 | 0 | 47.682 | 51.245 | 56.843 | 60.3 | 62.223 | 26.627 | 26.579 |
| Deferred Tax Liabilities Non-Current
| 0.934 | 0.405 | 13.835 | 5.535 | 3.069 | 1.416 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 39.306 | 71.862 | 25.986 | 19.532 | 17.484 | 13.83 | 16.246 | 8.669 | 5.764 |
| Total Non-Current Liabilities
| 76.469 | 76.028 | 93.068 | 85.687 | 77.395 | 75.547 | 78.469 | 35.295 | 32.344 |
| Total Liabilities
| 497.099 | 479.686 | 360.959 | 262.915 | 192.335 | 226.272 | 208.507 | 153.865 | 164.493 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 406.8 | 406.8 | 406.8 | 406.8 | 406.8 | 360.3 | 360.3 | 360.3 | 360.3 |
| Retained Earnings
| 1,550.424 | 955.014 | 530.798 | 311.77 | 167.884 | 71.994 | 13.278 | -1.31 | -5.918 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 73.464 | 46.152 | 29.177 | 18.666 | 13.089 | 124.267 | 123.706 |
| Other Total Stockholders Equity
| 596.093 | 514.587 | 396.539 | 396.539 | 396.539 | 112.593 | 112.593 | 124.267 | 123.706 |
| Total Shareholders Equity
| 2,553.316 | 1,876.401 | 1,407.6 | 1,161.26 | 1,000.399 | 563.554 | 499.26 | 483.257 | 478.088 |
| Total Equity
| 2,553.316 | 1,876.401 | 1,407.6 | 1,161.26 | 1,000.399 | 563.554 | 499.26 | 483.257 | 478.088 |
| Total Liabilities & Shareholders Equity
| 3,050.415 | 2,356.087 | 1,768.56 | 1,424.175 | 1,192.734 | 789.825 | 707.766 | 637.122 | 642.581 |